UK lawmakers push to end Palantir's £330M NHS contract, citing dependency on US AI firm

Parliamentary Committee Targets Palantir's Role in NHS Data Management

The UK government faces mounting pressure to sever ties with Palantir after a parliamentary committee labeled the US AI firm Palantir an "unacceptable point of weakness" in public services 1

1

. The Science, Innovation and Technology Committee issued a stark recommendation Wednesday: exercise the break clause in Palantir's £330M NHS data contract to prevent vendor lock-in and reduce dependency on foreign technology providers 2

2

.

The NHS Federated Data Platform sits at the heart of the controversy. Awarded in 2023 under the previous Conservative government for seven years, this AI-enabled system links health data across services in England and supports clinical decision-making 1

1

. The parliamentary committee singled out Palantir as the technology provider it found most concerning, arguing the UK risks becoming overly dependent on a single foreign firm for critical health infrastructure 1

1

.

Structural Concerns Drive Call for Break Clause

The committee's objection centers on concentration rather than specific wrongdoing. Once a platform like the FDP embeds itself across services, switching away becomes expensive and disruptive—precisely the vendor lock-in the break clause was designed to prevent 1

1

. Committee chairwoman Chi Onwurah stated: "The UK can and should be aiming for technology sovereignty in critical parts of our public sector and supporting domestic alternatives through smarter procurement" 2

2

.

Palantir, co-founded by Peter Thiel with support from America's CIA, has drawn criticism from patient groups and MPs over how much identifiable patient data the company's systems can access 1

1

2

2

. Campaign groups have warned about risks related to mass surveillance, infringements on individual freedoms, and data protection 2

2

.

Privacy and Sovereignty Concerns Extend Beyond Healthcare

The controversy extends beyond the NHS contract. London's mayor's office blocked a two-year, £50-million contract between Palantir and the Metropolitan police, citing inadequate demonstration of value for money 2

2

. Committee member Martin Wrigley raised concerns that US authorities could invoke US law to force Palantir to disclose information, potentially affecting a trial deal with the UK's Financial Conduct Authority 2

2

.

Palantir's UK head Louis Mosley defended the company's work, stating: "The committee has decided to put the politics of the playground before public services, arguing for the rejection of technology that is proven to deliver more NHS operations, less crime and better military capability" 2

2

. The company maintains it operates under the contracting authority's control and that tight encryption prevents unauthorized data access 2

2

.

What Comes Next for UK Government Decision

The UK government now faces a complex decision. Triggering the break clause would mean unwinding a platform already integrated into NHS operations, creating its own costs and disruption 1

1

. Ministers must weigh political pressure against the practical challenges of replacement. The committee proposed either finding an alternative UK provider or developing an in-house system 2

2

.

This episode reflects a wider European debate about technological sovereignty, where over-reliance on US data providers for critical infrastructure—from cloud to AI to health data—has become a recurring concern 1

1

. Palantir serves as a visible test case because health data represents the most sensitive category and the NHS the most politically charged institution. The committee's conclusions were "not ideologically motivated or driven by concerns about the quality of their products," but focused on the vulnerability created by reliance on a small number of US-based providers that could leave public services "at the mercy of foreign actors" 2

2

.